Lymphedema Diagnostics Market Growth, Status, CAGR, Value, Share and 2019-2024 Future Prediction

(The Express Wire via Comtex)

ReportsnReports released a new research report of 165 pages on title 'Global Lymphedema Diagnostics Market Insights by Application, Product Type, Competitive Landscape & Regional Forecast 2024' with detailed analysis, forecast and strategies.

2019 Research Report on Global Lymphedema Diagnostics Market is a professional and comprehensive report on the Lymphedema Diagnostics industry.

#Download Free PDF Sample Brochure of report Global Lymphedema Diagnostics Market 2019 across with 165 Pages and in-depth TOC Analysis @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2651531

Key Players: GE Healthcare (US), Philips (Netherlands), Siemens Healthineers (Germany), Canon, Inc. (Japan), Shimadzu Corporation (Japan), Stryker Corporation (US), Fluoptics (France), United Imaging Healthcare Co., Ltd. (China), Hitachi, Ltd. (Japan), Esaote, SpA (Italy), Neusoft Corporation (China), Mindray Medical International, Ltd. (China), Mitaka USA, Inc. (US), Curadel, LLC (US), and ImpediMed Ltd. (Australia).

“The lymphedema diagnostics market is projected to grow at a CAGR of 7.4% during the forecast period.”

The global lymphedema diagnostics market is projected to reach USD 35 million by 2024 from USD 24 million in 2019, at a CAGR of 7.4%. The major factors driving the growth of this market include the increasing global prevalence of cancer and lymphedema; technological advancements in diagnostic imaging modalities; and increasing investments, funds, and grants by public-private organizations. However, the high cost of diagnostic imaging systems, the short half-life of radiopharmaceuticals, and the limited supply of helium are expected to hinder the growth of this market.

“The lymphoscintigraphy segment accounted for the largest market share in 2018.”

Based on technology, the lymphedema diagnostics market is segmented into lymphoscintigraphy, magnetic resonance imaging (MRI), ultrasound imaging, computed tomography (CT), X-ray lymphography, bioimpedance analysis, and near-infrared fluorescence imaging. The lymphoscintigraphy segment accounted for the largest share of the lymphedema diagnostics market in 2018. The noninvasive nature and easy reproducibility of this technology, and the fact that lymphoscintigraphy does not adversely affect the lymphatic vascular endothelium are some of the key advantages supporting the adoption of this technology.

“The cancer segment accounted for the largest share of the lymphedema diagnostics market in 2018.”

On the basis of disease type, the lymphedema diagnostics market is segmented into cancer, inflammatory diseases, cardiovascular disease, and other diseases (congenital abnormalities, trauma-related conditions, infections, and filariasis). The cancer segment accounted for the largest share of the lymphedema diagnostics market in 2018. The large share of this segment can be attributed to the rising prevalence of cancer-associated lymphedema and increasing awareness about early disease diagnosis.

Get Flat 20% Discount on this Latest Research Report @ https://www.reportsnreports.com/contacts/discount.aspx?name=2651531

“Europe to account for the second-largest share of the global market in 2019.”

The lymphedema diagnostics market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. Europe is expected to account for the second-largest share of the global lymphedema diagnostics market in 2019. The rising incidence of chronic diseases and injuries, growing demand for early diagnosis and treatment, technological advancements, product launches, and increasing government and public-private investments for developing novel diagnostic imaging modalities are the major factors driving market growth in Europe.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 (25%), Tier 2 (30%), and Tier 3 (42%)
  • By Designation: C-level (26%), Director-level (30%), and Others (44%)
  • By Region: North America (34%), Europe (26%), APAC (23%), and RoW (17%)

Research Coverage: This report studies the lymphedema diagnostics market based on technology, disease type, end user, and region. The report also studies factors (such as drivers and restraints) affecting market growth. In addition, it analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions(and the respective countries in these regions).

Download Free Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2651531

In the end, the Global Lymphedema Diagnostics Market report’s conclusion part notes the estimation of the industry veterans.

Connect Us for more information at [email protected] or Call Us + 1 888 391 5441.

About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers and in-depth market research studies of over 5000 micro markets.

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Lymphedema Diagnostics Market Growth, Status, CAGR, Value, Share and 2019-2024 Future Prediction